Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Rheumatology

SAPHO Medicines: Pause Before Dental Work or Surgery?

At a Glance

SAPHO medicines should not be stopped automatically before dental work or surgery. A rheumatologist, dentist, surgeon, and anesthesia team should create a drug-specific plan that balances infection, bleeding, wound healing, and flare risks; urgent care should not be delayed.

There is no universal rule for whether you should pause your SAPHO syndrome medications before dental work or surgery. The decision requires a personalized, drug-specific plan. Automatically stopping all medications is not recommended and can cause severe disease flares [1]. You will need your rheumatologist, surgeon, dentist, and anesthesiologist to coordinate a written plan before any procedure.

If you have an urgent surgical emergency or an active dental infection, do not delay care to wait for a medication “washout” period. Instead, give the treating team your complete medication list, including the exact time of your last dose, so they can manage any risks immediately.

The Balancing Act: Infection vs. Flare

When planning for a procedure, your care team weighs two main risks:

  1. Infection and Healing: Some medications suppress the immune system, increasing the risk of post-surgical infections or delayed wound healing.
  2. Disease Flare: SAPHO syndrome naturally has a relapsing-remitting course. Holding treatments for too long increases your risk of a severe flare of skin issues or bone inflammation (osteitis) [1]. Because no single treatment universally controls all SAPHO manifestations, keeping your disease stable is a priority [2].

DMARDs and Biologics: A Drug-Specific Approach

Not all immune-modulating drugs are handled the same way.

  • Conventional DMARDs (disease-modifying antirheumatic drugs, like methotrexate or sulfasalazine) can often be continued through many surgeries without being stopped [3].
  • Biologics and Targeted Drugs (such as TNF inhibitors) are more likely to be paused. For major elective surgeries like joint replacement, guidelines recommend scheduling the surgery at the very end of your “dosing cycle” (when the drug level in your body is lowest) [4][3].

However, guidelines for joint replacements do not universally apply to all other surgeries or routine dental fillings [5]. Your rheumatologist must evaluate the exact procedure to decide whether to continue or hold your dose.

Restarting: If a drug is paused, it should not be restarted on a rigid timetable. Doctors typically wait to restart these medications until they can confirm your wound is healing properly and there are no signs of active infection (such as fever, worsening redness, or drainage) [6].

Bisphosphonates, Dental Work, and Jaw Health

Many people with SAPHO syndrome take bisphosphonates to treat bone pain and inflammation [7]. A major concern with these drugs during dental procedures—especially extractions or implants—is MRONJ (medication-related osteonecrosis of the jaw), a rare condition where the jawbone fails to heal properly [8].

If you need dental work while taking bisphosphonates, keep these facts in mind:

  • Risk varies: Your risk for MRONJ depends heavily on the specific drug, whether it is given by IV or pill, your dose, and how long you have taken it.
  • Do not delay necessary care: While unnecessary extractions should be avoided, you should not leave an active dental infection or a non-restorable tooth untreated. Discuss tooth-preserving options with your dentist, but proceed with necessary treatments [9][10].
  • “Drug holidays” are not proven: Evidence does not show that routinely stopping bisphosphonates shortly before dental work prevents MRONJ [11].
  • Blood tests are not universal clearance: A serum CTX test (which measures bone turnover) is not a reliable predictor of MRONJ risk and should not be used as a strict clearance test for surgery [12].

NSAIDs, Blood Thinners, and Corticosteroids

  • NSAIDs: Nonsteroidal anti-inflammatory drugs (NSAIDs) are a primary SAPHO treatment. Bleeding risk varies depending on the specific NSAID and procedure [13]. Your doctor may pause them if you have chronic kidney disease (where NSAIDs can trigger acute kidney injury) or if you have severe heart disease [14][15].
  • Blood Thinners and Aspirin: Do not confuse standard NSAIDs with prescribed low-dose aspirin or prescription blood thinners (anticoagulants). Taking NSAIDs alongside blood thinners heavily increases your bleeding risk [16][17]. Never stop prescribed aspirin or blood thinners without direct instructions from the prescribing doctor.
  • Corticosteroids: If you take daily steroids (like prednisone), never stop them abruptly before surgery. Stopping suddenly can cause a life-threatening condition called adrenal crisis [18]. Most patients continue their usual daily dose through surgery, but the anesthesia team must know your exact dose to plan safely [19].

Building Your Perioperative Plan

Make sure every member of your care team has your current medication list and a brief summary of your SAPHO history.

  • Identify the procedure: Is it a routine filling, an extraction, or major surgery?
  • Get it in writing: Ensure you have a written plan that explicitly states which drugs to stop, when to stop them, and the clinical criteria for restarting them.
  • Know the warning signs: Ask your surgeon what symptoms (such as fever, spreading facial swelling, a nonhealing extraction site, or wound drainage) require immediate medical attention.

Common questions in this guide

Should I stop all of my SAPHO medicines before dental work or surgery?
No. There is no universal rule, and stopping every medicine on your own can trigger a SAPHO flare. Your rheumatologist, dentist, surgeon, and anesthesia team should make a drug- and procedure-specific written plan; urgent surgery or an active dental infection should not be delayed for a washout.
Do methotrexate and biologic medicines need to be stopped before surgery?
Conventional DMARDs such as methotrexate or sulfasalazine can often be continued for many operations. Biologics and targeted medicines are more likely to be held or scheduled near the end of a dosing cycle for major elective surgery, but this does not automatically apply to every operation or dental procedure. Follow the plan from your rheumatologist and surgical team.
Should I take a bisphosphonate holiday before a tooth extraction?
Routine short-term stopping of a bisphosphonate has not been proven to prevent medication-related osteonecrosis of the jaw, also called MRONJ. Risk depends on the exact drug, dose, route, and treatment duration, so your dentist and prescribing clinician should decide how to manage it. Do not leave an active infection or a tooth that cannot be restored untreated while waiting for a drug holiday.
Can I keep taking NSAIDs, aspirin, or blood thinners before a procedure?
Do not stop prescribed aspirin or an anticoagulant without direct instructions from the clinician who prescribed it. NSAIDs may increase bleeding risk and may need adjustment based on the procedure, kidney function, and heart disease, especially when combined with blood thinners. Give the full medication list to the care team.
Is it safe to stop prednisone before surgery?
Do not stop daily prednisone or another corticosteroid abruptly, because sudden withdrawal can cause a life-threatening adrenal crisis. Many patients continue their usual dose through surgery, but the anesthesia team needs the exact dose and duration to plan safely.
When can I restart a SAPHO medicine after surgery or dental work?
If a medicine is paused, it is usually restarted only after the clinician confirms that the wound is healing properly and there is no active infection. Fever, worsening redness, drainage, spreading facial swelling, or a nonhealing extraction site should prompt contact with the treating team. The restart date should be individualized rather than based on a fixed timetable.

Get notified when new evidence is published on SAPHO syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (19)
  1. 1

    Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: review and update.

    Liu S, Tang M, Cao Y, Li C

    Therapeutic advances in musculoskeletal disease 2020; (12()):1759720X20912865 doi:10.1177/1759720X20912865.

    PMID: 32523634
  2. 2

    Treatment and monitoring of SAPHO syndrome: a systematic review.

    Li SWS, Roberts E, Hedrich C

    RMD open 2023; (9(4)) doi:10.1136/rmdopen-2023-003688.

    PMID: 38151265
  3. 3

    Perioperative management of patients with inflammatory rheumatic diseases : Updated recommendations of the German Society for Rheumatology.

    Albrecht K, Poddubnyy D, Leipe J, et al.

    Zeitschrift fur Rheumatologie 2023; (82(Suppl 1)):1-11 doi:10.1007/s00393-021-01150-9.

    PMID: 35235025
  4. 4

    2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.

    Goodman SM, Springer BD, Chen AF, et al.

    The Journal of arthroplasty 2022; (37(9)):1676-1683 doi:10.1016/j.arth.2022.05.043.

    PMID: 35732511
  5. 5

    Peri-Arthroscopic Management of Immunosuppressive Medications in Patients with Rheumatic Disease A Survey of Practice Trends Among Rheumatologists and Sports Medicine Orthopedic Surgeons.

    Vasavada K, Jazrawi LM, Samuels J

    Bulletin of the Hospital for Joint Disease (2013) 2024; (82(3)):186-193.

    PMID: 39150872
  6. 6

    2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.

    Goodman SM, Springer BD, Chen AF, et al.

    Arthritis care & research 2022; (74(9)):1399-1408 doi:10.1002/acr.24893.

    PMID: 35718887
  7. 7

    [Diagnosis and treatment of chronic nonbacterial osteitis (CNO) and SAPHO syndrome : Implications of the current consensus recommendations of an international commission of experts for German rheumatology].

    Assmann G, Klemm PCM, Hedrich C, et al.

    Zeitschrift fur Rheumatologie 2026; (85(2)):93-105 doi:10.1007/s00393-025-01741-w.

    PMID: 41313366
  8. 8

    Efficacy and Safety of Bisphosphonates in Chronic Non-bacterial Osteomyelitis of the Mandible: A Systematic Review.

    Howlader D, Daga D, Das A, et al.

    Calcified tissue international 2025; (116(1)):47 doi:10.1007/s00223-025-01354-0.

    PMID: 40055217
  9. 9

    Mandibular involvement in SAPHO syndrome: a retrospective study.

    Wang M, Li Y, Cao Y, et al.

    Orphanet journal of rare diseases 2020; (15(1)):312 doi:10.1186/s13023-020-01589-0.

    PMID: 33153463
  10. 10

    SAPHO syndrome in the mandible: A 17-patient-based experience.

    Cai Z, Liu Y, Xue J, et al.

    Journal of stomatology, oral and maxillofacial surgery 2025; (126(1)):102027 doi:10.1016/j.jormas.2024.102027.

    PMID: 39214251
  11. 11

    The Effect of Antiresorptive Drug Holidays on Medication-Related Osteonecrosis of the Jaw: A Systematic Review and Meta-Analysis.

    Aboalela AA, Farook FF, Alqahtani AS, et al.

    Cureus 2022; (14(10)):e30485 doi:10.7759/cureus.30485.

    PMID: 36415385
  12. 12

    Value of pre-operative CTX serum levels in the prediction of medication-related osteonecrosis of the jaw (MRONJ): a retrospective clinical study.

    Salgueiro M, Stribos M, Zhang LF, et al.

    The EPMA journal 2019; (10(1)):21-29 doi:10.1007/s13167-019-0160-3.

    PMID: 30984311
  13. 13

    Post-Operative Bleed Risks Associated with Perioperative Nonsteroidal Anti-Inflammatory Drugs: A Narrative Review.

    Seitz LL, Juresic S, Siegel LR, Smith NT

    Journal of pain & palliative care pharmacotherapy 2025; (39(4)):518-524 doi:10.1080/15360288.2025.2547839.

    PMID: 40828145
  14. 14

    Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis.

    Zhang X, Donnan PT, Bell S, Guthrie B

    BMC nephrology 2017; (18(1)):256 doi:10.1186/s12882-017-0673-8.

    PMID: 28764659
  15. 15

    Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations.

    Szeto CC, Sugano K, Wang JG, et al.

    Gut 2020; (69(4)):617-629 doi:10.1136/gutjnl-2019-319300.

    PMID: 31937550
  16. 16

    Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.

    Schjerning Olsen AM, Gislason GH, McGettigan P, et al.

    JAMA 2015; (313(8)):805-14 doi:10.1001/jama.2015.0809.

    PMID: 25710657
  17. 17

    Cardiovascular Safety and Bleeding Risk Associated with Nonsteroidal Anti-Inflammatory Medications in Patients with Cardiovascular Disease.

    Ross SJ, Elgendy IY, Bavry AA

    Current cardiology reports 2017; (19(1)):8 doi:10.1007/s11886-017-0814-5.

    PMID: 28138824
  18. 18

    European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency.

    Beuschlein F, Else T, Bancos I, et al.

    European journal of endocrinology 2024; (190(5)):G25-G51 doi:10.1093/ejendo/lvae029.

    PMID: 38714321
  19. 19

    Risks and Management of Glucocorticoid Therapy for Patients with Rheumatic Disease Having Surgery.

    Modha K, Whinney C

    Current rheumatology reports 2026; (28(1)).

    PMID: 42236615

This page explains how SAPHO medicines may be managed around dental procedures and surgery for informational purposes only; it does not constitute medical advice. Your rheumatologist, dentist, surgeon, anesthesiologist, and prescribing clinician should create a plan for your situation.